As Merck, AstraZeneca and other drugmakers sign on, Medicare price negotiations face critical moment

A deadline looms to sign drug-price negotiation agreements as industry watches for legal reprieve.

Related Keywords

Ohio ,United States ,Washington ,Brandon Barford ,Donald Trump ,Chris Meekins ,Michael Newman ,Raksha Dondapati ,Raymond James ,Us District Court ,Merck Co ,Abbvie Inc ,Medicaid Services ,Office Of Management ,A Bristol Myers Squibb Co ,Boehringer Ingelheim ,Amgen Inc ,Centers For Medicare ,Astrazeneca ,Us Supreme Court ,Us Chamber ,Inflation Reduction ,Southern District ,President Donald Trump ,Beacon Policy ,Novo Nordisk ,Inflation Reduction Act ,Article Normal ,Biotechnology Services ,Pharmaceuticals ,Insurance ,Non Life Insurance ,Health Medical Insurance ,Healthcare Life Sciences ,Professional Bodies ,Business Consumer Services ,Biopharmaceuticals ,Financial Services ,Government Sponsored Health Insurance ,Corporate Crime Legal Action ,Regulation Government Policy ,Corporate Industrial News ,Political General News ,Crime Legal Action ,Politics International Relations ,Domestic Politics ,Content Types ,Factiva Filters ,C Amp Ampe Executive News Filter ,C Amp Ampe Industry News Filter ,Merck Amp Co Inc ,Mrk ,Astrazeneca Plc Adr ,Azn ,Bristol Myers Squibb Co ,Bmy ,Johnson Amp ,Jnj ,Amgn ,Abbv ,Novo Nordiskas Adr ,Nvo ,Corporate Crime ,Legal Action ,Regulation ,Government Policy ,Corporate ,Industrial News ,Political ,General News ,Crime ,Politics ,International Relations ,Health ,Medical Insurance ,Healthcare ,Life Sciences ,Business ,Consumer Services ,